{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:31:16Z","timestamp":1790188276728,"version":"4.1.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T00:00:00Z","timestamp":1732752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T00:00:00Z","timestamp":1732752000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["UM1 AI068618"],"award-info":[{"award-number":["UM1 AI068618"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["UM1 AI069481"],"award-info":[{"award-number":["UM1 AI069481"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["UM1 AI069501"],"award-info":[{"award-number":["UM1 AI069501"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["UM1 AI069534"],"award-info":[{"award-number":["UM1 AI069534"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["UM1 AI068635"],"award-info":[{"award-number":["UM1 AI068635"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["P30 CA015704"],"award-info":[{"award-number":["P30 CA015704"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-024-54580-9","type":"journal-article","created":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T11:15:57Z","timestamp":1732792557000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Enhanced and sustained biodistribution of HIV-1 neutralizing antibody VRC01LS in human genital and rectal mucosa"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3530-9310","authenticated-orcid":false,"given":"Maria P.","family":"Lemos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rena D.","family":"Astronomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1546-6172","authenticated-orcid":false,"given":"Yunda","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep","family":"Narpala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhu","family":"Prabhakaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8130-2032","authenticated-orcid":false,"given":"Philipp","family":"Mann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8640-6623","authenticated-orcid":false,"given":"Carmen A.","family":"Paez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiwen","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory J.","family":"Mize","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayley","family":"Glantz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharine","family":"Westerberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6660-8460","authenticated-orcid":false,"given":"Hunter","family":"Colegrove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2329-8298","authenticated-orcid":false,"given":"Kimberly S.","family":"Smythe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minggang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert H.","family":"Pierce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Hutter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Frank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Mascola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian B.","family":"McDermott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0755-4386","authenticated-orcid":false,"given":"Linda-Gail","family":"Bekker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2276-7117","authenticated-orcid":false,"given":"M. Juliana","family":"McElrath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,28]]},"reference":[{"key":"54580_CR1","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1126\/science.1187659","volume":"329","author":"X Wu","year":"2010","unstructured":"Wu, X. et al. Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1. Science 329, 856\u2013861 (2010).","journal-title":"Science"},{"key":"54580_CR2","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1126\/science.1192819","volume":"329","author":"T Zhou","year":"2010","unstructured":"Zhou, T. et al. Structural basis for broad and potent neutralization of HIV-1 by antibody VRC01. Science 329, 811\u2013817 (2010).","journal-title":"Science"},{"key":"54580_CR3","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1056\/NEJMoa2031738","volume":"384","author":"L Corey","year":"2021","unstructured":"Corey, L. et al. Two randomized trials of neutralizing antibodies to prevent HIV-1 acquisition. N. Engl. J. Med. 384, 1003\u20131014 (2021).","journal-title":"N. Engl. J. Med."},{"key":"54580_CR4","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1038\/s41591-022-01953-6","volume":"28","author":"PB Gilbert","year":"2022","unstructured":"Gilbert, P. B. et al. Neutralization titer biomarker for antibody-mediated prevention of HIV-1 acquisition. Nat. Med. 28, 1924\u20131932 (2022).","journal-title":"Nat. Med."},{"key":"54580_CR5","doi-asserted-by":"publisher","first-page":"e1002493","DOI":"10.1371\/journal.pmed.1002493","volume":"15","author":"MR Gaudinski","year":"2018","unstructured":"Gaudinski, M. R. et al. Safety and pharmacokinetics of the Fc-modified HIV-1 human monoclonal antibody VRC01LS: A Phase 1 open-label clinical trial in healthy adults. PLoS Med. 15, e1002493 (2018).","journal-title":"PLoS Med."},{"key":"54580_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.712122","volume":"12","author":"SR Walsh","year":"2021","unstructured":"Walsh, S. R. & Seaman, M. S. Broadly neutralizing antibodies for HIV-1 prevention. Front. Immunol. 12, 712122 (2021).","journal-title":"Front. Immunol."},{"key":"54580_CR7","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.immuni.2007.01.007","volume":"26","author":"F Hladik","year":"2007","unstructured":"Hladik, F. et al. Initial events in establishing vaginal entry and infection by human immunodeficiency virus type-1. Immunity 26, 257\u2013270 (2007).","journal-title":"Immunity"},{"key":"54580_CR8","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1097\/QAI.0b013e3182898392","volume":"63","author":"MJ McElrath","year":"2013","unstructured":"McElrath, M. J. et al. Comprehensive assessment of HIV target cells in the distal human gut suggests increasing HIV susceptibility toward the anus. J. Acquir Immune Defic. Syndr. 63, 263\u2013271 (2013).","journal-title":"J. Acquir Immune Defic. Syndr."},{"key":"54580_CR9","doi-asserted-by":"publisher","first-page":"e108954","DOI":"10.1371\/journal.pone.0108954","volume":"9","author":"MP Lemos","year":"2014","unstructured":"Lemos, M. P. et al. The inner foreskin of healthy males at risk of HIV infection harbors epithelial CD4+ CCR5+ cells and has features of an inflamed epidermal barrier. PLoS One 9, e108954 (2014).","journal-title":"PLoS One"},{"key":"54580_CR10","doi-asserted-by":"publisher","first-page":"144","DOI":"10.3389\/fimmu.2019.00144","volume":"10","author":"SM Gonzalez","year":"2019","unstructured":"Gonzalez, S. M., Aguilar-Jimenez, W., Su, R. C. & Rugeles, M. T. Mucosa: Key interactions determining sexual transmission of the HIV infection. Front. Immunol. 10, 144 (2019).","journal-title":"Front. Immunol."},{"key":"54580_CR11","doi-asserted-by":"publisher","first-page":"11604","DOI":"10.1128\/JVI.01361-13","volume":"87","author":"K Klein","year":"2013","unstructured":"Klein, K. et al. Neutralizing IgG at the portal of infection mediates protection against vaginal simian\/human immunodeficiency virus challenge. J. Virol. 87, 11604\u201311616 (2013).","journal-title":"J. Virol."},{"key":"54580_CR12","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1038\/nature13612","volume":"514","author":"SY Ko","year":"2014","unstructured":"Ko, S. Y. et al. Enhanced neonatal Fc receptor function improves protection against primate SHIV infection. Nature 514, 642\u2013645 (2014).","journal-title":"Nature"},{"key":"54580_CR13","doi-asserted-by":"publisher","first-page":"505","DOI":"10.4049\/jimmunol.2100253","volume":"207","author":"AM Carias","year":"2021","unstructured":"Carias, A. M. et al. Anatomic distribution of intravenously injected IgG takes approximately 1 week to achieve stratum corneum saturation in vaginal tissues. J. Immunol. 207, 505\u2013511 (2021).","journal-title":"J. Immunol."},{"key":"54580_CR14","first-page":"3969","volume":"46","author":"DG Covell","year":"1986","unstructured":"Covell, D. G. et al. Pharmacokinetics of monoclonal immunoglobulin G1, F(ab\u2019)2, and Fab\u2019 in mice. Cancer Res. 46, 3969\u20133978 (1986).","journal-title":"Cancer Res."},{"key":"54580_CR15","doi-asserted-by":"publisher","first-page":"3041","DOI":"10.4049\/jimmunol.139.9.3041","volume":"139","author":"OD Holton","year":"1987","unstructured":"Holton, O. D. et al. Biodistribution of monoclonal IgG1, F(ab\u2019)2, and Fab\u2019 in mice after intravenous injection. Comparison between anti-B cell (anti-Lyb8.2) and irrelevant (MOPC-21) antibodies. J. Immunol. 139, 3041\u20133049 (1987).","journal-title":"J. Immunol."},{"key":"54580_CR16","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1093\/intimm\/10.9.1289","volume":"10","author":"J Borvak","year":"1998","unstructured":"Borvak, J. et al. Functional expression of the MHC class I-related receptor, FcRn, in endothelial cells of mice. Int. Immunol. 10, 1289\u20131298 (1998).","journal-title":"Int. Immunol."},{"key":"54580_CR17","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1093\/intimm\/dxg018","volume":"15","author":"WardES Zhou","year":"2003","unstructured":"Zhou, WardE. S., Ghetie, J. & Ober, V. RJ. Evidence to support the cellular mechanism involved in serum IgG homeostasis in humans. Int. Immunol. 15, 187\u2013195 (2003).","journal-title":"Int. Immunol."},{"key":"54580_CR18","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1002\/psp4.12224","volume":"6","author":"JT Ryman","year":"2017","unstructured":"Ryman, J. T. & Meibohm, B. Pharmacokinetics of monoclonal antibodies. CPT Pharmacomet. Syst. Pharm. 6, 576\u2013588 (2017).","journal-title":"CPT Pharmacomet. Syst. Pharm."},{"key":"54580_CR19","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1083\/jcb.200809122","volume":"185","author":"S Tzaban","year":"2009","unstructured":"Tzaban, S. et al. The recycling and transcytotic pathways for IgG transport by FcRn are distinct and display an inherent polarity. J. Cell Biol. 185, 673\u2013684 (2009).","journal-title":"J. Cell Biol."},{"key":"54580_CR20","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1208\/s12248-009-9157-5","volume":"12","author":"M Tabrizi","year":"2010","unstructured":"Tabrizi, M., Bornstein, G. G. & Suria, H. Biodistribution mechanisms of therapeutic monoclonal antibodies in health and disease. AAPS J. 12, 33\u201343 (2010).","journal-title":"AAPS J."},{"key":"54580_CR21","doi-asserted-by":"publisher","first-page":"4388","DOI":"10.1073\/pnas.1012861108","volume":"108","author":"Z Li","year":"2011","unstructured":"Li, Z. et al. Transfer of IgG in the female genital tract by MHC class I-related neonatal Fc receptor (FcRn) confers protective immunity to vaginal infection. Proc. Natl. Acad. Sci. USA 108, 4388\u20134393 (2011).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"54580_CR22","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.3389\/fimmu.2019.01540","volume":"10","author":"M Pyzik","year":"2019","unstructured":"Pyzik, M. et al. The neonatal Fc receptor (FcRn): A misnomer? Front. Immunol. 10, 1540 (2019).","journal-title":"Front. Immunol."},{"key":"54580_CR23","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1517\/17425255.2015.1027682","volume":"11","author":"ML Cottrell","year":"2015","unstructured":"Cottrell, M. L., Srinivas, N. & Kashuba, A. D. Pharmacokinetics of antiretrovirals in mucosal tissue. Expert Opin. Drug Metab. Toxicol. 11, 893\u2013905 (2015).","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"54580_CR24","first-page":"138","volume":"25","author":"SP Buchbinder","year":"2018","unstructured":"Buchbinder, S. P. Maximizing the benefits of HIV preexposure prophylaxis. Top. Antivir. Med. 25, 138\u2013142 (2018).","journal-title":"Top. Antivir. Med."},{"key":"54580_CR25","first-page":"764","volume":"96","author":"RP MacDermott","year":"1989","unstructured":"MacDermott, R. P. et al. Alterations in serum immunoglobulin G subclass in patients with ulcerative colitis and Crohn's disease. Gastroenterology 96, 764\u2013768 (1989).","journal-title":"Gastroenterology"},{"key":"54580_CR26","doi-asserted-by":"publisher","first-page":"S39","DOI":"10.1164\/ajrccm.164.supplement_2.2106065","volume":"164","author":"DM McDonald","year":"2001","unstructured":"McDonald, D. M. Angiogenesis and remodeling of airway vasculature in chronic inflammation. Am. J. Respir. Crit. Care Med. 164, S39\u2013S45 (2001).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"54580_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-02954-0","volume":"11","author":"P Sobia","year":"2021","unstructured":"Sobia, P. et al. Higher mucosal antibody concentrations in women with genital tract inflammation. Sci. Rep. 11, 23514 (2021).","journal-title":"Sci. Rep."},{"key":"54580_CR28","unstructured":"Waldmann, T. A., Strober, W. & Blaese, R. M. in Progress in Immunology - First International Congress of Immunology (ed Amos D. B.). (Academic Press, 1971)."},{"key":"54580_CR29","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1046\/j.1365-2249.1996.36742.x","volume":"104","author":"WH Kutteh","year":"1996","unstructured":"Kutteh, W. H., Prince, S. J., Hammond, K. R., Kutteh, C. C. & Mestecky, J. Variations in immunoglobulins and IgA subclasses of human uterine cervical secretions around the time of ovulation. Clin. Exp. Immunol. 104, 538\u2013542 (1996).","journal-title":"Clin. Exp. Immunol."},{"key":"54580_CR30","unstructured":"Kutteh, W. H. Mucosal immunity in the human female reproductive tract. Mucosal Immunology, Second Edition (eds Ogra, P. L. et al). (Academic Press, 1999)."},{"key":"54580_CR31","doi-asserted-by":"publisher","first-page":"3266","DOI":"10.4049\/jimmunol.166.5.3266","volume":"166","author":"X Zhu","year":"2001","unstructured":"Zhu, X. et al. MHC class I-related neonatal Fc receptor for IgG is functionally expressed in monocytes, intestinal macrophages, and dendritic cells. J. Immunol. 166, 3266\u20133276 (2001).","journal-title":"J. Immunol."},{"key":"54580_CR32","doi-asserted-by":"publisher","first-page":"e1003776","DOI":"10.1371\/journal.ppat.1003776","volume":"9","author":"S Gupta","year":"2013","unstructured":"Gupta, S. et al. The Neonatal Fc receptor (FcRn) enhances human immunodeficiency virus type 1 (HIV-1) transcytosis across epithelial cells. PLoS Pathog. 9, e1003776 (2013).","journal-title":"PLoS Pathog."},{"key":"54580_CR33","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1097\/QAI.0000000000002892","volume":"89","author":"S Takuva","year":"2022","unstructured":"Takuva, S. et al. Infusion reactions after receiving the broadly neutralizing antibody VRC01 or placebo to reduce HIV-1 acquisition: Results from the phase 2b antibody-mediated prevention randomized trials. J. Acquir Immune Defic. Syndr. 89, 405\u2013413 (2022).","journal-title":"J. Acquir Immune Defic. Syndr."},{"key":"54580_CR34","doi-asserted-by":"publisher","unstructured":"Astronomo, R. D. et al. Rectal tissue and vaginal tissue from intravenous VRC01 recipients show protection against ex vivo HIV-1 challenge. J. Clin. Invest. 131, https:\/\/doi.org\/10.1172\/jci146975 (2021).","DOI":"10.1172\/jci146975"},{"key":"54580_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.jim.2021.112995","volume":"491","author":"M Prabhakaran","year":"2021","unstructured":"Prabhakaran, M. et al. A sensitive method to quantify HIV-1 antibodies in mucosal samples. J. Immunol. Methods 491, 112995 (2021).","journal-title":"J. Immunol. Methods"},{"key":"54580_CR36","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/cei.12692","volume":"182","author":"JE Ledgerwood","year":"2015","unstructured":"Ledgerwood, J. E. et al. Safety, pharmacokinetics and neutralization of the broadly neutralizing HIV-1 human monoclonal antibody VRC01 in healthy adults. Clin. Exp. Immunol. 182, 289\u2013301 (2015).","journal-title":"Clin. Exp. Immunol."},{"key":"54580_CR37","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1038\/s41591-022-01762-x","volume":"28","author":"JP Casazza","year":"2022","unstructured":"Casazza, J. P. et al. Safety and tolerability of AAV8 delivery of a broadly neutralizing antibody in adults living with HIV: a phase 1, dose-escalation trial. Nat. Med. 28, 1022\u20131030 (2022).","journal-title":"Nat. Med."},{"key":"54580_CR38","doi-asserted-by":"publisher","first-page":"e1002435","DOI":"10.1371\/journal.pmed.1002435","volume":"14","author":"KH Mayer","year":"2017","unstructured":"Mayer, K. H. et al. Safety, pharmacokinetics, and immunological activities of multiple intravenous or subcutaneous doses of an anti-HIV monoclonal antibody, VRC01, administered to HIV-uninfected adults: Results of a phase 1 randomized trial. PLoS Med. 14, e1002435 (2017).","journal-title":"PLoS Med."},{"key":"54580_CR39","doi-asserted-by":"publisher","first-page":"e0245638","DOI":"10.1371\/journal.pone.0245638","volume":"16","author":"S Ram","year":"2021","unstructured":"Ram, S. et al. Pixelwise H-score: A novel digital image analysis-based metric to quantify membrane biomarker expression from immunohistochemistry images. PLoS ONE 16, e0245638 (2021).","journal-title":"PLoS ONE"},{"key":"54580_CR40","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1038\/bjc.1992.144","volume":"65","author":"CF Molthoff","year":"1992","unstructured":"Molthoff, C. F., Pinedo, H. M., Schluper, H. M., Nijman, H. W. & Boven, E. Comparison of the pharmacokinetics, biodistribution and dosimetry of monoclonal antibodies OC125, OV-TL 3, and 139H2 as IgG and F(ab\u2019)2 fragments in experimental ovarian cancer. Br. J. Cancer 65, 677\u2013683 (1992).","journal-title":"Br. J. Cancer"},{"key":"54580_CR41","first-page":"1517","volume":"54","author":"LT Baxter","year":"1994","unstructured":"Baxter, L. T., Zhu, H., Mackensen, D. G. & Jain, R. K. Physiologically based pharmacokinetic model for specific and nonspecific monoclonal antibodies and fragments in normal tissues and human tumor xenografts in nude mice. Cancer Res. 54, 1517\u20131528 (1994).","journal-title":"Cancer Res."},{"key":"54580_CR42","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.jim.2017.07.009","volume":"450","author":"JR Schneider","year":"2017","unstructured":"Schneider, J. R. et al. Long-term direct visualization of passively transferred fluorophore-conjugated antibodies. J. Immunol. Methods 450, 66\u201372 (2017).","journal-title":"J. Immunol. Methods"},{"key":"54580_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28727-5","volume":"13","author":"DR Beckford-Vera","year":"2022","unstructured":"Beckford-Vera, D. R. et al. First-in-human immunoPET imaging of HIV-1 infection using (89)Zr-labeled VRC01 broadly neutralizing antibody. Nat. Commun. 13, 1219 (2022).","journal-title":"Nat. Commun."},{"key":"54580_CR44","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s10928-013-9332-2","volume":"40","author":"Y Cao","year":"2013","unstructured":"Cao, Y., Balthasar, J. P. & Jusko, W. J. Second-generation minimal physiologically-based pharmacokinetic model for monoclonal antibodies. J. Pharmacokinet. Pharmacodyn. 40, 597\u2013607 (2013).","journal-title":"J. Pharmacokinet. Pharmacodyn."},{"key":"54580_CR45","doi-asserted-by":"publisher","first-page":"e0132942","DOI":"10.1371\/journal.pone.0132942","volume":"10","author":"M Patyka","year":"2015","unstructured":"Patyka, M., Malamud, D., Weissman, D., Abrams, W. R. & Kurago, Z. Periluminal distribution of HIV-binding target cells and Gp340 in the oral, cervical and sigmoid\/rectal mucosae: A mapping study. PLoS ONE 10, e0132942 (2015).","journal-title":"PLoS ONE"},{"key":"54580_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-12732-2","volume":"10","author":"J Cantero-Perez","year":"2019","unstructured":"Cantero-Perez, J. et al. Resident memory T cells are a cellular reservoir for HIV in the cervical mucosa. Nat. Commun. 10, 4739 (2019).","journal-title":"Nat. Commun."},{"key":"54580_CR47","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1208\/s12248-012-9395-9","volume":"14","author":"Y Chen","year":"2012","unstructured":"Chen, Y. & Balthasar, J. P. Evaluation of a catenary PBPK model for predicting the in vivo disposition of mAbs engineered for high-affinity binding to FcRn. AAPS J. 14, 850\u2013859 (2012).","journal-title":"AAPS J."},{"key":"54580_CR48","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1095\/biolreprod.110.090423","volume":"85","author":"CD Blaskewicz","year":"2011","unstructured":"Blaskewicz, C. D., Pudney, J. & Anderson, D. J. Structure and function of intercellular junctions in human cervical and vaginal mucosal epithelia. Biol. Reprod. 85, 97\u2013104 (2011).","journal-title":"Biol. Reprod."},{"key":"54580_CR49","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1111\/aji.12230","volume":"71","author":"DJ Anderson","year":"2014","unstructured":"Anderson, D. J., Marathe, J. & Pudney, J. The structure of the human vaginal stratum corneum and its role in immune defense. Am. J. Reprod. Immunol. 71, 618\u2013623 (2014).","journal-title":"Am. J. Reprod. Immunol."},{"key":"54580_CR50","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s11930-021-00305-8","volume":"13","author":"A Dubinskaya","year":"2021","unstructured":"Dubinskaya, A., Guthrie, T., Anger, J. T., Eilber, K. S. & Berman, J. R. Local genital arousal: Mechanisms for vaginal lubrication. Curr. Sex. Heath Rep. 13, 45\u201353 (2021).","journal-title":"Curr. Sex. Heath Rep."},{"key":"54580_CR51","doi-asserted-by":"publisher","first-page":"3136","DOI":"10.1182\/blood.V98.10.3136","volume":"98","author":"WK Bleeker","year":"2001","unstructured":"Bleeker, W. K., Teeling, J. L. & Hack, C. E. Accelerated autoantibody clearance by intravenous immunoglobulin therapy: studies in experimental models to determine the magnitude and time course of the effect. Blood 98, 3136\u20133142 (2001).","journal-title":"Blood"},{"key":"54580_CR52","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1038\/mi.2013.120","volume":"7","author":"YY Wang","year":"2014","unstructured":"Wang, Y. Y. et al. IgG in cervicovaginal mucus traps HSV and prevents vaginal herpes infections. Mucosal Immunol. 7, 1036\u20131044 (2014).","journal-title":"Mucosal Immunol."},{"key":"54580_CR53","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1126\/science.aag0491","volume":"353","author":"J Liu","year":"2016","unstructured":"Liu, J. et al. Antibody-mediated protection against SHIV challenge includes systemic clearance of distal virus. Science 353, 1045\u20131049 (2016).","journal-title":"Science"},{"key":"54580_CR54","doi-asserted-by":"publisher","first-page":"e042247","DOI":"10.1136\/bmjopen-2020-042247","volume":"10","author":"S Mahomed","year":"2020","unstructured":"Mahomed, S. et al. Assessing the safety and pharmacokinetics of the anti-HIV monoclonal antibody CAP256V2LS alone and in combination with VRC07-523LS and PGT121 in South African women: study protocol for the first-in-human CAPRISA 012B phase I clinical trial. BMJ Open 10, e042247 (2020).","journal-title":"BMJ Open"},{"key":"54580_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-021-00305-8","volume":"6","author":"KE Seaton","year":"2021","unstructured":"Seaton, K. E. et al. Meta-analysis of HIV-1 vaccine elicited mucosal antibodies in humans. NPJ Vaccines 6, 56 (2021).","journal-title":"NPJ Vaccines"},{"key":"54580_CR56","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.4049\/jimmunol.2000320","volume":"205","author":"J Czartoski","year":"2020","unstructured":"Czartoski, J. et al. Rapid collection of human rectal secretions using OriCol devices is suitable for measurement of mucosal Ig without blood contamination. J. Immunol. 205, 2312\u20132320 (2020).","journal-title":"J. Immunol."},{"key":"54580_CR57","doi-asserted-by":"publisher","first-page":"2653","DOI":"10.1093\/bioinformatics\/btt456","volume":"29","author":"Y Fong","year":"2013","unstructured":"Fong, Y., Sebestyen, K., Yu, X., Gilbert, P. & Self, S. nCal: an R package for non-linear calibration. Bioinformatics 29, 2653\u20132654 (2013).","journal-title":"Bioinformatics"},{"key":"54580_CR58","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S0165-0378(98)00086-2","volume":"42","author":"RD Franklin","year":"1999","unstructured":"Franklin, R. D. & Kutteh, W. H. Characterization of immunoglobulins and cytokines in human cervical mucus: influence of exogenous and endogenous hormones. J. Reprod. Immunol. 42, 93\u2013106 (1999).","journal-title":"J. Reprod. Immunol."},{"key":"54580_CR59","first-page":"571","volume":"102","author":"AK Ildgruben","year":"2003","unstructured":"Ildgruben, A. K., Sjoberg, I. M. & Hammarstrom, M. L. Influence of hormonal contraceptives on the immune cells and thickness of human vaginal epithelium. Obstet. Gynecol. 102, 571\u2013582 (2003).","journal-title":"Obstet. Gynecol."},{"key":"54580_CR60","doi-asserted-by":"publisher","unstructured":"Wessels, J. M., Felker, A. M., Dupont, H. A. & Kaushic, C. The relationship between sex hormones, the vaginal microbiome and immunity in HIV-1 susceptibility in women. Dis. Model Mech. 11, https:\/\/doi.org\/10.1242\/dmm.035147 (2018).","DOI":"10.1242\/dmm.035147"},{"key":"54580_CR61","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.733619","volume":"11","author":"EH Byrne","year":"2021","unstructured":"Byrne, E. H. et al. Antigen presenting cells link the female genital tract microbiome to mucosal inflammation, with hormonal contraception as an additional modulator of inflammatory signatures. Front. Cell Infect. Microbiol. 11, 733619 (2021).","journal-title":"Front. Cell Infect. Microbiol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-54580-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-54580-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-54580-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T13:03:18Z","timestamp":1732798998000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-54580-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,28]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["54580"],"URL":"https:\/\/doi.org\/10.1038\/s41467-024-54580-9","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,28]]},"assertion":[{"value":"17 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.R.M. is listed on patent 9738703 for the VRC01 antibody (patent held by the US National Institutes of Health). M.P., J.H., and S.N. are current employees of the US NIH. All other authors have no competing interests to declare. The study funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10332"}}